SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-20-126261
Filing Date
2020-04-29
Accepted
2020-04-29 16:23:05
Documents
7
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEFA14A d854810ddefa14a.htm DEFA14A 32278
2 GRAPHIC g854810g05e15.jpg GRAPHIC 23408
3 GRAPHIC g854810g16q56.jpg GRAPHIC 13701
4 GRAPHIC g854810g48k66.jpg GRAPHIC 28639
5 GRAPHIC g854810g62d05.jpg GRAPHIC 24728
6 GRAPHIC g854810g76c99.jpg GRAPHIC 32714
7 GRAPHIC g854810g87n84.jpg GRAPHIC 13084
  Complete submission text file 0001193125-20-126261.txt   221562
Mailing Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135
Business Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135 617-225-0096
PROTEOSTASIS THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: DEFA14A | Act: 34 | File No.: 001-37695 | Film No.: 20830672
SIC: 2834 Pharmaceutical Preparations